TCTC Holdings LLC Sells 7,600 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

TCTC Holdings LLC trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 46,488 shares of the pharmacy operator’s stock after selling 7,600 shares during the period. TCTC Holdings LLC’s holdings in Walgreens Boots Alliance were worth $434,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in WBA. Principal Financial Group Inc. grew its position in Walgreens Boots Alliance by 2.9% in the 3rd quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator’s stock worth $7,940,000 after purchasing an additional 24,974 shares in the last quarter. Sigma Planning Corp boosted its stake in Walgreens Boots Alliance by 4.2% in the third quarter. Sigma Planning Corp now owns 31,632 shares of the pharmacy operator’s stock valued at $283,000 after acquiring an additional 1,282 shares during the last quarter. Crossmark Global Holdings Inc. boosted its stake in Walgreens Boots Alliance by 16.5% in the third quarter. Crossmark Global Holdings Inc. now owns 56,647 shares of the pharmacy operator’s stock valued at $508,000 after acquiring an additional 8,031 shares during the last quarter. Apollon Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 29.9% in the third quarter. Apollon Wealth Management LLC now owns 13,035 shares of the pharmacy operator’s stock valued at $117,000 after acquiring an additional 2,998 shares during the last quarter. Finally, Aptus Capital Advisors LLC boosted its stake in Walgreens Boots Alliance by 37.6% in the third quarter. Aptus Capital Advisors LLC now owns 14,445 shares of the pharmacy operator’s stock valued at $129,000 after acquiring an additional 3,950 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $11.23 on Monday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market capitalization of $9.70 billion, a PE ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62. The company’s 50 day simple moving average is $10.83 and its two-hundred day simple moving average is $9.76.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period in the prior year, the company posted $0.66 EPS. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. Analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Royal Bank of Canada boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.